Skip to main content
OpenTrials

Clinical trial condition

Urogenital Neoplasms

Explore clinical trials studying Urogenital Neoplasms. Study availability and eligibility vary by location and protocol.

12,007 public trials 2,555 recruiting studies
Refine in advanced search Browse all conditions

Urogenital Neoplasms trial results

Recruiting

A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer

NCT07082920

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Columbia University Medical Center New York, United States
  • University Hospitals Cleveland Medical Center Cleveland, Ohio, United States
  • Fred Hutchinson Cancer Center Seattle, Washington, United States
View Trial Details
Recruiting

A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

NCT06095089

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • University Of Minnesota Minneapolis, Minnesota, United States
  • START New Jersey East Brunswick, New Jersey, United States
View all 19 locations
View Trial Details
Recruiting

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

NCT06319820

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations
  • Arkansas Urology Little Rock, Arkansas, United States
  • Genesis Research LLC Los Alamitos, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Irvine Medical Center Orange, California, United States
View all 193 locations
View Trial Details
Recruiting

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

NCT06582017

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Cancer, +54 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer Los Angeles, California, United States
  • Cedars-Sanai Medical Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport, California, United States
View Trial Details
Recruiting

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

NCT07186842

Conditions
Adnexal Diseases, Advanced Solid Cancers, Bile Duct Diseases, +29 more
Locations
  • SCRI at HCA Health One Denver, Colorado, United States
  • Florida Cancer Specialists Orlando, Florida, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Monash Health Clayton, Australia
View all 17 locations
View Trial Details

Related conditions